Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC

NCT06081673 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Penpulimab injection
DRUG: cisplatin
DRUG: albumin-paclitaxel

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University